Trial Profile
A bioequivalence study of two formulations of pridopidine.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 28 Sep 2011
Price :
$35
*
At a glance
- Drugs Pridopidine (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- 28 Sep 2011 New trial record